Soichiro Saikawa

1.0k total citations
26 papers, 593 citations indexed

About

Soichiro Saikawa is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Soichiro Saikawa has authored 26 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hepatology, 16 papers in Epidemiology and 8 papers in Molecular Biology. Recurrent topics in Soichiro Saikawa's work include Liver Disease Diagnosis and Treatment (15 papers), Liver Disease and Transplantation (11 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Soichiro Saikawa is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Liver Disease and Transplantation (11 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Soichiro Saikawa collaborates with scholars based in Japan. Soichiro Saikawa's co-authors include Hitoshi Yoshiji, Tadashi Namisaki, Kosuke Kaji, Hideto Kawaratani, Shinya Sato, Kei Moriya, Mitsuteru Kitade, Masanori Furukawa, Keisuke Nakanishi and Kenichiro Seki and has published in prestigious journals such as International Journal of Molecular Sciences, CHEST Journal and Journal of Hepatology.

In The Last Decade

Soichiro Saikawa

25 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Soichiro Saikawa Japan	13	245	228	185	130	127	26	593
Kenichiro Seki Japan	15	307 1.3×	219 1.0×	132 0.7×	145 1.1×	157 1.2×	37	732
Nozomu Wada Japan	15	243 1.0×	115 0.5×	285 1.5×	116 0.9×	61 0.5×	45	560
Rashmee Patil United States	10	477 1.9×	223 1.0×	180 1.0×	92 0.7×	218 1.7×	20	706
Abdul M. Oseini United States	14	577 2.4×	290 1.3×	251 1.4×	206 1.6×	159 1.3×	23	937
Roman Liebe Germany	11	260 1.1×	135 0.6×	192 1.0×	105 0.8×	72 0.6×	36	468
Kazuhide Takata Japan	10	178 0.7×	120 0.5×	139 0.8×	239 1.8×	158 1.2×	54	577
Norihiro Imai Japan	13	399 1.6×	113 0.5×	380 2.1×	107 0.8×	95 0.7×	71	692
Hideko Ohama Japan	13	267 1.1×	121 0.5×	258 1.4×	107 0.8×	54 0.4×	53	659
Juanwen Zhang China	12	230 0.9×	116 0.5×	83 0.4×	92 0.7×	103 0.8×	25	503
Roberto Caporale Italy	14	255 1.0×	272 1.2×	175 0.9×	125 1.0×	42 0.3×	30	861

Countries citing papers authored by Soichiro Saikawa

Since Specialization

Citations

This map shows the geographic impact of Soichiro Saikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soichiro Saikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soichiro Saikawa more than expected).

Fields of papers citing papers by Soichiro Saikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soichiro Saikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soichiro Saikawa. The network helps show where Soichiro Saikawa may publish in the future.

Co-authorship network of co-authors of Soichiro Saikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Soichiro Saikawa. A scholar is included among the top collaborators of Soichiro Saikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soichiro Saikawa. Soichiro Saikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakashima, Koki, et al.. (2025). An 85-Year-Old Man With Dyspnea and a History of Hormone Therapy for Prostate Adenocarcinoma. CHEST Journal. 168(3). e69–e74.

Furukawa, Masanori, Akira Mitoro, Yukihisa Fujinaga, et al.. (2021). Efficacy of Underwater Endoscopic Mucosal Resection for Superficial Non-Ampullary Duodenal Epithelial Tumor. Clinical Endoscopy. 54(3). 371–378. 18 indexed citations

Tsuji, Yuki, Tadashi Namisaki, Kosuke Kaji, et al.. (2020). Comparison of serum fibrosis biomarkers for diagnosing significant liver fibrosis in patients with chronic hepatitis B. Experimental and Therapeutic Medicine. 20(2). 985–995. 15 indexed citations

Sato, Shinya, Tadashi Namisaki, Masanori Furukawa, et al.. (2020). Effect of L‑carnitine on health‑related quality of life in patients with liver cirrhosis. Biomedical Reports. 13(6). 1–1. 9 indexed citations

Kitagawa, Koh, Kei Moriya, Kosuke Kaji, et al.. (2020). Atorvastatin Augments Gemcitabine-Mediated Anti-Cancer Effects by Inhibiting Yes-Associated Protein in Human Cholangiocarcinoma Cells. International Journal of Molecular Sciences. 21(20). 7588–7588. 16 indexed citations

Takaya, Hiroaki, Tadashi Namisaki, Mitsuteru Kitade, et al.. (2019). Acylcarnitine: Useful biomarker for early diagnosis of hepatocellular carcinoma in non-steatohepatitis patients. World Journal of Gastrointestinal Oncology. 11(10). 887–897. 5 indexed citations

Moriya, Kei, Tadashi Namisaki, Shinya Sato, et al.. (2019). Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients. Clinical and Molecular Hepatology. 25(4). 381–389. 12 indexed citations

Sato, Shinya, Kei Moriya, Masanori Furukawa, et al.. (2019). Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection. Clinical and Molecular Hepatology. 25(1). 65–73. 6 indexed citations

Sawada, Yasuhiko, Hideto Kawaratani, Takuya Kubo, et al.. (2019). Effect of furosemide on muscle cramps in patients with liver cirrhosis. Journal of Gastroenterology and Hepatology. 35(1). 76–81. 6 indexed citations

10.

Kitade, Mitsuteru, Kosuke Kaji, Norihisa Nishimura, et al.. (2019). Blocking development of liver fibrosis augments hepatic progenitor cell‐derived liver regeneration in a mouse chronic liver injury model. Hepatology Research. 49(9). 1034–1045. 6 indexed citations

11.

Takaya, Hiroaki, Tadashi Namisaki, Mitsuteru Kitade, et al.. (2019). VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma. BMC Gastroenterology. 19(1). 167–167. 24 indexed citations

12.

Nakanishi, Keisuke, Kosuke Kaji, Mitsuteru Kitade, et al.. (2019). Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model. International Journal of Molecular Sciences. 20(11). 2724–2724. 24 indexed citations

13.

Saikawa, Soichiro, Kosuke Kaji, Norihisa Nishimura, et al.. (2018). Angiotensin receptor blockade attenuates cholangiocarcinoma cell growth by inhibiting the oncogenic activity of Yes-associated protein. Cancer Letters. 434. 120–129. 32 indexed citations

14.

Takaya, Hiroaki, Hideto Kawaratani, Yuki Tsuji, et al.. (2018). von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C. United European Gastroenterology Journal. 6(9). 1401–1409. 35 indexed citations

15.

Moriya, Kei, Tadashi Namisaki, Shinya Sato, et al.. (2018). Efficacy of bi-monthly hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma. Journal of Gastrointestinal Oncology. 9(4). 741–749. 14 indexed citations

16.

Sawada, Yasuhiko, Hideto Kawaratani, Takuya Kubo, et al.. (2018). Combining probiotics and an angiotensin‐II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non‐alcoholic steatohepatitis. Hepatology Research. 49(3). 284–295. 29 indexed citations

17.

Kaji, Kosuke, Hiroaki Takaya, Soichiro Saikawa, et al.. (2017). Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity. World Journal of Gastroenterology. 23(47). 8355–8366. 76 indexed citations

18.

Kaji, Kosuke, Norihisa Nishimura, Kenichiro Seki, et al.. (2017). Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake. International Journal of Cancer. 142(8). 1712–1722. 189 indexed citations

19.

Okura, Yasushi, Tadashi Namisaki, Kei Moriya, et al.. (2016). Combined treatment with dipeptidyl peptidase‐4 inhibitor (sitagliptin) and angiotensin‐II type 1 receptor blocker (losartan) suppresses progression in a non‐diabetic rat model of steatohepatitis. Hepatology Research. 47(12). 1317–1328. 22 indexed citations

20.

Nakatani, Toshiya, Yukihisa Fujinaga, Kenichiro Seki, et al.. (2013). [A case of infectious mononucleosis with splenic infarction].. PubMed. 110(8). 1461–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact